Status:
COMPLETED
A Study of Plasmatic Concentrations of Endothelin-1 (ET1), Atrial Natriuretic Peptide (ANP) and Brain Natriuretic Peptide (BNP) in Acute Ischemic Stroke.
Lead Sponsor:
University Hospital, Strasbourg, France
Conditions:
Stroke
Eligibility:
All Genders
18+ years
Brief Summary
A study of plasmatic concentrations of endothelin-1 (ET1), atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) in acute ischemic stroke.
Eligibility Criteria
Inclusion
- male or female
- age \> 18
- with an ischemic stroke
Exclusion
- cardiac failure
- renal failure
Key Trial Info
Start Date :
November 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2004
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT00213785
Start Date
November 1 2001
End Date
March 1 2004
Last Update
November 29 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique neurologique - Service des maladies du système nerveux et du muscle - Hôpitaux Universitaires de Strasbourg, Hôpital Civil
Strasbourg, France, 67091